ODDO BHF Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.6M Buy
66,070
+6,859
+12% +$1.48M 0.77% 44
2026
Q1
$12.9M Buy
59,211
+2,144
+4% +$476K 0.51% 54
2025
Q4
$13M Buy
57,067
+12,552
+28% +$2.86M 0.49% 52
2025
Q3
$10.3M Sell
44,515
-3,088
-6% -$629K 0.39% 65
2025
Q2
$8.84M Sell
47,603
-727
-2% -$135K 0.34% 82
2025
Q1
$10.1M Buy
48,330
+17,952
+59% +$3.49M 0.42% 69
2024
Q4
$5.4M Buy
30,378
+6,232
+26% +$1.15M 0.27% 95
2024
Q3
$4.77M Buy
+24,146
New +$4.51M 0.24% 93

Other funds holding ABBV

ODDO BHF Asset Management's ABBV Position: Q2 2026 in Review

ODDO BHF Asset Management increased its AbbVie (ABBV) stake by 12% in Q2 2026, buying an estimated $1.48M and bringing the position to 66,070 shares worth $16.6M. The position accounts for 0.77% of the portfolio, ranked #44.

ODDO BHF Asset Management first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • ODDO BHF Asset Management held 66,070 shares of AbbVie worth $16.6M as of Q2 2026.
  • ODDO BHF Asset Management bought 6,859 AbbVie shares in Q2 2026, an estimated $1.48M.
  • AbbVie made up 0.77% of ODDO BHF Asset Management's portfolio in Q2 2026, its #44 holding.
  • ODDO BHF Asset Management first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on ODDO BHF Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.